• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Better Therapeutics

Better Therapeutics, Glooko partner on digital diabetes management

January 4, 2024 By Sean Whooley

Better Therapeutics BT-001 diabetes digital therapeutic

Better Therapeutics and Glooko today announced a partnership to integrate technologies and enhance diabetes management. The partnership aims to integrate Better Therapeutics’ ApsyreRx digital behavioral treatment into Glooko’s diabetes management platform. Better Therapeutics designed AspyreRx to treat type 2 diabetes. The FDA authorized AspyreRx as a prescription digital therapeutic for diabetes in July. Palo Alto, […]

Filed Under: Business/Financial News, Diabetes, Featured, Patient Monitoring, Technology Tagged With: Better Therapeutics, glooko

Better Therapeutics wins FDA nod for type 2 diabetes digital therapeutic

July 11, 2023 By Sean Whooley

Better Therapeutics BT-001 diabetes digital therapeutic

Better Therapeutics (Nasdaq:BTTX) announced that the FDA authorized its AspyreRx prescription digital therapeutic for diabetes. AspyreRx, formerly BT-001, provides cognitive behavioral therapy to patients 18 years or older with type 2 diabetes. The prescription-only digital therapeutic (PDT) underwent review through the FDA de novo pathway. The company submitted an FDA de novo request in September 2022 for […]

Filed Under: Business/Financial News, Clinical Trials, Diabetes, Featured, Food & Drug Administration (FDA), Neurological, Patient Monitoring, Technology Tagged With: Better Therapeutics, FDA

Better Therapeutics hopes FDA nod for diabetes digital therapeutic comes in 2023

March 30, 2023 By Sean Whooley

Better Therapeutics BT-001 diabetes digital therapeutic

Better Therapeutics (Nasdaq:BTTX) shares ticked up on fourth-quarter results and projections for its flagship product in 2023. The company’s quarterly results come on the heels of a 35% headcount reduction. Better Therapeutics said the headcount cut comes as part of a cost reduction initiative. It aims to improve its cash runway and “focus on the long-term success […]

Filed Under: Business/Financial News, Diabetes, Food & Drug Administration (FDA), MassDevice Earnings Roundup, Technology, Wall Street Beat Tagged With: Better Therapeutics

Better Therapeutics names new chief commercial officer

October 27, 2022 By Sean Whooley

Better Therapeutics BT-001 diabetes digital therapeutic

Better Therapeutics (Nasdaq:BTTX) announced today that it appointed Diane Gomez-Thinnes as its new chief commercial officer (CCO). Gomez-Thinnes’ appointment became effective yesterday, Oct. 26, 2022. She joins the San Francisco-based company, which develops prescription digital therapeutics (PDTs). They use a novel form of cognitive behavioral therapy (CBT) to address the root causes of cardiometabolic diseases, […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Personnel, Technology Tagged With: Better Therapeutics, Personnel Moves

Published data backs digital therapeutic for diabetes from Better Therapeutics

October 4, 2022 By Sean Whooley

Better Therapeutics BT-001 diabetes digital therapeutic

Better Therapeutics (Nasdaq:BTTX) announced today that newly published data supports its digital therapeutic for type 2 diabetes. San Francisco-based Better Therapeutics develops the BT-001 prescription digital therapeutic (PDT). It potentially represents the first-in-class PDT using cognitive behavioral therapy (CBT) to treat type 2 diabetes. In July, the company completed the pivotal trial for its BT-001 digital therapeutic […]

Filed Under: Clinical Trials, Diabetes, Patient Monitoring, Technology Tagged With: Better Therapeutics

7 innovative digital health offerings to treat diabetes

September 28, 2022 By Sean Whooley

MIT Insulin Dosing device diabetes

From using your smartphone to track data to reversing your diabetes altogether, these digital health technologies stand out. Advances in treatments for diabetes never stop coming. Whether that be in the form of insulin pumps or continuous glucose monitors, we’ve seen plenty. Moving away from the physical device, innovations in the digital diabetes space continue […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Better Therapeutics, dariohealth, Dexcom, Diabetes, Glytec, Onduo, One Drop, Sword Health, Verily, Virta Health, Zillion

Better Therapeutics submits FDA de novo request for type 2 diabetes treatment

September 22, 2022 By Sean Whooley

Better Therapeutics

Better Therapeutics (Nasdaq:BTTX) announced today that it submitted a de novo classification request to the FDA for its BT-001 technology. San Francisco-based Better Therapeutics seeks marketing authorization for the BT-001 prescription digital therapeutic (PDT). It potentially represents the first-in-class PDT using cognitive behavioral therapy (CBT) to treat type 2 diabetes. Marketing initially would cover type […]

Filed Under: Business/Financial News, Diabetes, Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Technology Tagged With: Better Therapeutics, FDA

Better Therapeutics Q2 beats Street as it prepares to submit diabetes therapy for FDA review

August 11, 2022 By Jim Hammerand

A portrait of Better Therapeutics CEO and President Frank Karbe

Better Therapeutics (Nasdaq:BTTX) posted second-quarter quarter results today that beat the consensus forecast on Wall Street as it prepared to submit its first product for FDA review. Better Therapeutics has not yet generated revenue from the commercialization or sale of any product. The company went public through a special purpose acquisition company merger in October. […]

Filed Under: Clinical Trials, Diabetes, Featured, Food & Drug Administration (FDA), Technology, Uncategorized Tagged With: Better Therapeutics, Diabetes

Better Therapeutics completes trial for type 2 diabetes treatment, will submit to FDA

July 28, 2022 By Sean Whooley

Better Therapeutics

Better Therapeutics (Nasdaq:BTTX) announced today that it completed the pivotal trial for its BT-001 digital therapeutic for diabetes. San Francisco-based Better Therapeutics designed its nutritional cognitive behavioral therapy (nCBT) platform to address the root causes of cardiometabolic diseases. It designed its investigational, first-in-class BT-001 prescription digital therapeutic (PDT) to use nCBT to treat type 2 […]

Filed Under: Big Data, Clinical Trials, Diabetes, Featured, Neurological, Patient Monitoring, Technology Tagged With: Better Therapeutics

Digital therapeutics developer Better Therapeutics names new CEO

June 7, 2022 By Sean Whooley

Better Therapeutics

Better Therapeutics (Nasdaq:BTTX) announced today that it appointed Frank Karbe as its new president and CEO. San Francisco-based Better Therapeutics develops prescription digital therapeutics (PDTs) based on nutritional cognitive behavioral therapy (nCBT) to address the root causes of cardiometabolic diseases. Karbe will join the company as president and CEO and will serve as a member […]

Filed Under: Business/Financial News, Diabetes, Neurological, Patient Monitoring, Personnel, Technology Tagged With: Better Therapeutics, Personnel, Personnel Moves

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS